Roche Holding AG logo

Roche Holding AG (RO)

Market Closed
10 Aug, 15:20
SIX SIX
378. 40
CHF
+5.8
+1.5566%
CHF
- Market Cap
17.54 P/E Ratio
10.85% Div Yield
21,634 Volume
0 Eps
372.6 CHF
Previous Close
Add Transaction
Day Range
372.6 378.4
Year Range
256.6 383
Want to track RO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

RO closed today higher at 378.4 CHF, an increase of 1.5566% from yesterday's close, completing a monthly increase of 11.3596% or 38.6 CHF. Over the past 12 months, RO stock gained 13.0227%.
RO pays dividends to its shareholders, with the most recent payment made on Mar 16, 2026. The next estimated payment will be in In 7 months on Mar 16, 2027 for a total of 10.799 CHF.
The last earnings report, released on Apr 23, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Roche Holding AG has completed 2 stock splits, with the recent split occurring on May 04, 2011.
The company's stock is traded on 9 different exchanges and in various currencies, with the primary listing on SIX (CHF).

RO Chart

Roche Holding AG (RO) FAQ

What is the stock price today?

The current price is 378.40 CHF.

On which exchange is it traded?

Roche Holding AG is listed on SIX.

What is its stock symbol?

The ticker symbol is RO.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 10.85%.

What is its market cap?

As of today, no market cap data is available.

Has Roche Holding AG ever had a stock split?

Roche Holding AG had 2 splits and the recent split was on May 04, 2011.

Roche Holding AG Profile

Pharmaceuticals Industry
Healthcare Sector
Thomas Schinecker CEO
SIX Exchange
CH0012032113 ISIN
CH Country
103,249 Employees
12 Mar 2026 Last Dividend
4 May 2011 Last Split
- IPO Date

Overview

Roche Holding AG is a global leader in healthcare, with a strong focus on pharmaceuticals and diagnostics. The company has a presence across Europe, North America, Latin America, Asia, Africa, Australia, and Oceania, showcasing a truly international footprint. Founded in 1896, Roche has a long-standing history of innovation and dedication to improving health outcomes. Based in Basel, Switzerland, this esteemed company has been at the forefront of developing and providing solutions to some of the most pressing health challenges faced around the world.

Products and Services

Roche Holding AG offers a broad portfolio of products and services, catering to a wide range of therapeutic areas and diagnostic needs:

  • Pharmaceutical Products

    These include a variety of medications aimed at treating conditions in therapeutic areas such as anemia, various types of blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune diseases, neurological disorders, ophthalmology, respiratory disorders, and transplantation. Roche is also actively developing new pharmaceutical products to address unmet medical needs in these and other areas.

  • In Vitro Diagnostic Tests

    Roche provides a comprehensive range of diagnostic tests for the detection of diseases like cancer, diabetes, Covid-19, hepatitis, human papillomavirus (HPV), among others. These diagnostic tools are essential in the early detection, diagnosis, and monitoring of diseases, leading to better patient outcomes.

  • Diagnostic Instruments

    The company also offers advanced diagnostic instruments used by laboratories, hospitals, and healthcare providers globally. These instruments are crucial for conducting the in vitro diagnostic tests, ensuring accuracy and efficiency in diagnostics.

  • Digital Health Solutions

    Understanding the increasing role of technology in healthcare, Roche is also involved in offering digital health solutions. These innovative technologies aim to improve patient care, enhance diagnostic and therapeutic processes, and enable healthcare providers to deliver more personalized and efficient care.

Contact Information

Address: Konzern Hauptsitz
Phone: 41 61 688 11 11